MSB 2.44% $1.10 mesoblast limited

Ann: P3 trial initiated, positive 24 mth P2 results in back pain, page-14

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    Its okay that posters theorize - no ones forcing their hands to buy or support the company. It astounds me however the ferocious interest shown by non-holders.
    Not only for this stock but many others. Its coming fairly stock standard now on HC.

    So I take my hat off to them , because despite not having any monetary reasons agendas, they spend heaps of time reading ALL the posts and some go to extraordinary efforts to explain there positions - not for there benefit (an absolutely rude thought to even think), but to ensure invested holders are fully up to date with alternative views. Its all fun and games I guess !

    On the P3 Disk Trials - one thing for certain - no postulating by the FDA. That makes it 3 x MPC applications approved by the FDA for Phase III commencement.
    (chf; disks ; bmt).

    Cheers all
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.028(2.44%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.14 $1.16 $1.09 $4.761M 4.287M

Buyers (Bids)

No. Vol. Price($)
32 360415 $1.10
 

Sellers (Offers)

Price($) Vol. No.
$1.10 840 4
View Market Depth
Last trade - 13.34pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.